Cambridge Investment Research Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 53,256 shares of TEVA stock, worth $951,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,256
Previous 46,655
14.15%
Holding current value
$951,684
Previous $658,000
31.46%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding TEVA
# of Institutions
603Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$768 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$649 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$578 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$520 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$515 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...